7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Adrenocortical Adenoma D018246 1 associated lipids
Hyperparathyroidism, Primary D049950 1 associated lipids
Breast Neoplasms, Male D018567 1 associated lipids
Severe Combined Immunodeficiency D016511 1 associated lipids
Hashimoto Disease D050031 1 associated lipids
Legg-Calve-Perthes Disease D007873 1 associated lipids
Fluorosis, Dental D009050 1 associated lipids
Bone Demineralization, Pathologic D018488 1 associated lipids
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative D054438 1 associated lipids
POEMS Syndrome D016878 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Kurz K et al. Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis. 2015 Dis. Markers pmid:26576067
Lewis JR et al. Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women. 2015 PLoS ONE pmid:26222774
Audo R et al. Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort. 2015 Arthritis Res. Ther. pmid:26220665
Wang J et al. RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients. 2015 PLoS ONE pmid:26218592
Ye M et al. Prednisone inhibits the focal adhesion kinase/receptor activator of NF-κB ligand/mitogen-activated protein kinase signaling pathway in rats with adriamycin-induced nephropathy. 2015 Mol Med Rep pmid:26459042
Priyadarshi S et al. Genetic association and altered gene expression of osteoprotegerin in otosclerosis patients. 2015 Ann. Hum. Genet. pmid:25998045
Yang Y et al. The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway. 2015 J. Biol. Chem. pmid:25979341
HaDuong JH et al. Interaction between bone marrow stromal cells and neuroblastoma cells leads to a VEGFA-mediated osteoblastogenesis. 2015 Int. J. Cancer pmid:25648303
Higgs JT et al. Variants of Osteoprotegerin Lacking TRAIL Binding for Therapeutic Bone Remodeling in Osteolytic Malignancies. 2015 Mol. Cancer Res. pmid:25636966
Jin Y et al. Functional role of mechanosensitive ion channel Piezo1 in human periodontal ligament cells. 2015 Angle Orthod pmid:24810489

Table of Content